NEW YORK (GenomeWeb) – Pressure Biosciences today reported its revenues from products and services increased 14 percent year over year for the third quarter ended Sept. 30, as its overall revenues slipped 11 percent.

Total revenues, generated wholly from the sale of products and services, were $372,545, down 11 percent from $420,762 in Q3 2013. Products and services revenue in Q3 2013 was $327,958. Consumables sales were $52,000, nearly flat with $51,000 for Q3 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.